FGF21 and diabetic kidney disease: Furthermore, FGF21 administration decreases cholesterol and triglyceride accumulation in the diabetic kidney, and markedly abolishes the increase of p65 protein in the proinflammatory NF-κB pathway, all contributing factors to the progression of diabetic nephropathy (63).